Osteoporosis Risk Assessment Instrument (ORAI)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
orai score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low risk0–8
  • High risk9–26
Direct Clinical Answer

The Osteoporosis Risk Assessment Instrument (ORAI) calculates classifying inflammatory arthritides and monitoring longitudinal autoimmune disease activity. Key inputs include age. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Identifies women at risk for osteoporosis and recommends bone densitometry. Uses age, weight, and current estrogen use to stratify risk in postmenopausal women.

Clinical Indication

The Osteoporosis Risk Assessment Instrument (ORAI) is indicated for bedside clinical practice to support Identifies women at risk for osteoporosis and recommends bone densitometry. Uses age, weight, and current estrogen use to stratify risk in postmenopausal women.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: Sensitivity 93.3%, specificity 46.4% at cutoff of 9 points.

Formula & Variables:

ORAI Score = Age points + Weight points + Estrogen use points

Input Parameters

NameTypeRequiredDescription
agestringYesAge range of the patient
weightstringYesWeight category of the patient
current_estrogen_usestringYesIs the patient currently using estrogen (hormone replacement therapy)?

Score Interpretation & Guidance

RangeStageDescription
0–8Low riskBone densitometry may not be needed
9–26High riskConsider bone densitometry

Evidence-Based References (EBM)

  • Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000 May 2;162(9):1289-94.
  • El Maghraoui A, Habbassi A, Ghazi M, Achemlal L, Mounach A, Nouijai A, et al. Validation and comparative evaluation of four osteoporosis risk assessment tools in Moroccan menopausal women. Arch Osteoporos. 2006 Dec;1(1-2):35-42. doi: 10.1007/s11657-006-0006-1.DOI: 10.1007/s11657-006-0006-1
  • Rubin KH, Abrahamsen B, Friis-Holmberg T, Hjelmborg JV, Bech M, Hermann AP, et al. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study. Bone. 2013 Sep;56(1):16-22. doi: 10.1016/j.bone.2013.05.002.DOI: 10.1016/j.bone.2013.05.002

Related calculators